MENU
XPH
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

XPH stock forecast, quote, news & analysis

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U... Show more

Category: #Health
XPH
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for XPH with price predictions
Jul 02, 2026

XPH in +2.91% Uptrend, rising for three consecutive days on June 29, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where XPH advanced for three days, in of 307 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 09, 2026. You may want to consider a long position or call options on XPH as a result. In of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for XPH just turned positive on June 10, 2026. Looking at past instances where XPH's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

XPH moved above its 50-day moving average on June 09, 2026 date and that indicates a change from a downward trend to an upward trend.

The Aroon Indicator entered an Uptrend today. In of 225 cases where XPH Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 14 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where XPH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

XPH broke above its upper Bollinger Band on June 24, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), ZOETIS (NYSE:ZTS), Elanco Animal Health (NYSE:ELAN), Intra-Cellular Therapies (NASDAQ:ITCI).

Industry description

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").

Market Cap

The average market capitalization across the State Street® SPDR® S&P® PhrmctlsETF ETF is 73.48B. The market cap for tickers in the group ranges from 454.4M to 1.08T. LLY holds the highest valuation in this group at 1.08T. The lowest valued company is EOLS at 454.4M.

High and low price notable news

The average weekly price growth across all stocks in the State Street® SPDR® S&P® PhrmctlsETF ETF was 4%. For the same ETF, the average monthly price growth was 21%, and the average quarterly price growth was 22%. PRGO experienced the highest price growth at 14%, while OMER experienced the biggest fall at -19%.

Volume

The average weekly volume growth across all stocks in the State Street® SPDR® S&P® PhrmctlsETF ETF was 20%. For the same stocks of the ETF, the average monthly volume growth was 59% and the average quarterly volume growth was 68%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 58
Price Growth Rating: 42
SMR Rating: 68
Profit Risk Rating: 69
Seasonality Score: 7 (-100 ... +100)
View a ticker or compare two or three
XPH
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Details
Category
Health
Address
SPDR Series TrustOne Lincoln Street Cph0326Boston
Phone
N/A
Web
www.spdrs.com
XPH in +2.91% Uptrend, rising for three consecutive days on June 29, 2026